Michael Brennan to Hematologic Neoplasms
This is a "connection" page, showing publications Michael Brennan has written about Hematologic Neoplasms.
Connection Strength
0.071
-
Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, Quinn B, Epstein JB, Blijlevens NM, Waltimo T, Passweg JR, Correa ME, Dahllöf G, Garming-Legert KU, Logan RM, Potting CM, Shapira MY, Soga Y, Stringer J, Stokman MA, Vokurka S, Wallhult E, Yarom N, Jensen SB. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2015 Jan; 23(1):223-36.
Score: 0.029
-
Daikeler T, Mauramo M, Rovó A, Stern M, Halter J, Buser A, Tyndall A, Häusermann P, Gratwohl A, Tichelli A, Brennan MT, Waltimo T. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Bone Marrow Transplant. 2013 Jul; 48(7):988-93.
Score: 0.026
-
Lockhart PB, Brennan MT, Kent ML, Packman CH, Norton HJ, Fox PC, Frenette G. Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplant. 2005 Apr; 35(7):713-20.
Score: 0.015